NiKem Research receives certification for GLP Bioanalysis
NiKem Research announced that it has received, from the Italian Ministry of Health, GLP certification of its bioanalysis facilities to further extend its drug discovery service capabilities.
NiKem Research has provided for many years bioanalytical support both for its in vitro ADME(T) and in vivo PK services associated to various drug discovery programs and as a standalone capability. The company is now able to offer bioanalysis as a GLP service to support clients preclinical PK and toxicology studies.
Giuseppe Giardina, CEO & Managing Director of NiKem, said “This new product is an important step in NiKem’s continuing expansion of its high quality, cost effective services to support progression of our clients’ drug discovery programmes”.
Most read news
Organizations
Other news from the department politics & laws

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Haemophilia_B
Aortic_insufficiency

New Detergents for Drug Research - So far, it is unclear why it is only possible to make intact membrane proteins available for drug research with the help of certain detergents
Personalized medicine: Functioning, induced liver cells from skin tissue - These cells can now be used to test therapeutic agents, among other things

Cholera bacteria form aggressive biofilm to kill immune cells - The study provides new insights into the infection strategies of pathogens
LifeSpan BioSciences to release 20,000 immunohistochemistry-validated reagent antibodies - Leader in antibody evaluation and validation expands focus to include development and sales of antibodies validated for use in immunohistochemistry

Could insulin come in a pill? - How a molecule that mimics insulin may advance diabetes research

Biomass production by reverse citric acid cycle - Central metabolic pathway runs "backwards" at high carbon dioxide concentrations
